Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, Becker T, Heilmann S, Yamany T, Duvic M, Hordinsky M, Norris D, Price VH, Mackay-Wiggan J, de Jong A, DeStefano GM, Moebus S, Bhm M, Blume-Peytavi U, Wolff H, Lutz G, Kruse R, Bian L, Amos CI, Lee A, Gregersen PK, Blaumeiser B, Altshuler D, Clynes R, de Bakker PIW, Nthen MM, Daly MJ, Christiano AM (2015) Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
Research stage only: Some animal studies use intravitreal peptide injection showing efficacy, but translating to human use requires extensive safety and formulation development
(2023) innovatively constructed a glioma microfluidic chip model to explore the BBB penetration and efficacy of antiglioma TCM components in the human body and glioma microenvironment
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
If you are already on Ozempic, Wegovy, Mounjaro, or Zepbound, a booster is redundant
Think of it like working with a personal trainer